JW (Cayman) Therapeutics Co Ltd (HKSE:02126)
HK$ 2.5 -0.07 (-2.72%) Market Cap: 1.04 Bil Enterprise Value: 321.96 Mil PE Ratio: 0 PB Ratio: 0.56 GF Score: 36/100

JW (Cayman) Therapeutics Co Ltd (HKSE:02126) Transcripts

    • 1